<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="preprint">
<?all-math-mml yes?>
<?use-mml?>
<?origin ukpmcpa?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">bioRxiv</journal-id>
<journal-title-group>
<journal-title>bioRxiv : the preprint server for biology</journal-title>
</journal-title-group>
<issn pub-type="ppub"/>
</journal-meta>
<article-meta>
<article-id pub-id-type="manuscript">EMS96494</article-id>
<article-id pub-id-type="doi">10.1101/2020.09.28.316307</article-id>
<article-id pub-id-type="archive">PPR219866</article-id>
<article-version article-version-type="publisher-id">1</article-version>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Fluorescence-detection size-exclusion chromatography utilizing nanobody technology for expression screening of membrane proteins</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Jin</surname>
<given-names>Fei</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Yao</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Mengqi</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sun</surname>
<given-names>Minxuan</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Hattori</surname>
<given-names>Motoyuki</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>State Key Laboratory of Genetic Engineering, Shanghai Key Laboratory of Bioactive Small Molecules, Collaborative Innovation Center of Genetics and Development, Department of Physiology and Biophysics, School of Life Sciences, Fudan University, Shanghai 200438, China</aff>
<author-notes>
<corresp id="CR1">Correspondence should be addressed to M.H. (<email>hattorim@fudan.edu.cn</email>).</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>30</day>
<month>09</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="preprint">
<day>28</day>
<month>09</month>
<year>2020</year>
</pub-date>
<permissions>
<license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
<license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND 4.0 International license</ext-link>.</license-p>
</license>
</permissions>
<abstract>
<p id="P1">Membrane proteins play numerous physiological roles and are thus of tremendous interest in pharmacology. Nevertheless, stable and homogeneous sample preparation is one of the bottlenecks in biophysical and pharmacological studies of membrane proteins because membrane proteins are typically unstable and poorly expressed. To overcome such obstacles, GFP fusion-based Fluorescence-detection Size-Exclusion Chromatography (FSEC) has been widely employed for membrane protein expression screening for over a decade. However, fused GFP itself may occasionally affect the expression and/or stability of the targeted membrane protein, leading to both false-positive and false-negative results in expression screening. Furthermore, GFP fusion technology is not well suited for some membrane proteins depending on their membrane topology. Here, we developed an FSEC assay utilizing nanobody (Nb) technology, named FSEC-Nb, in which targeted membrane proteins are fused to a small peptide tag and recombinantly expressed. The whole-cell extracts are solubilized, mixed with anti-peptide Nb fused to GFP and applied to a size-exclusion chromatography column attached to a fluorescence detector for FSEC analysis. FSEC-Nb enables one to evaluate the expression, monodispersity and thermostability of membrane proteins without the need of purification by utilizing the benefits of the GFP fusion-based FSEC method, but does not require direct GFP fusion to targeted proteins. We applied FSEC-Nb to screen zinc-activated ion channel (ZAC) family proteins in the Cys-loop superfamily and membrane proteins from SARS-CoV-2 as examples of the practical application of FSEC-Nb. We successfully identified a ZAC ortholog with high monodispersity but moderate expression levels that could not be identified with the previously developed GFP fusion-free FSEC method. Consistent with the results of FSEC-Nb screening, the purified ZAC ortholog showed monodispersed particles by both negative staining EM and cryo-EM. Furthermore, we identified two membrane proteins from SARS-CoV-2 with high monodispersity and expression level by FSEC-Nb, which may facilitate structural and functional studies of SARS-CoV-2. Overall, our results show FSEC-Nb as a powerful tool for membrane protein expression screening that can provide further opportunity to prepare well-behaved membrane proteins for structural and functional studies.</p>
</abstract>
</article-meta>
</front>
<body>
<sec id="S1" sec-type="intro">
<title>Introduction</title>
<p id="P2">Biophysical and biochemical studies, especially the structural determination of membrane proteins, require stable and homogeneous sample preparations, the acquisition of which is often hindered by the poor expression and unstable nature of membrane proteins<sup>
<xref ref-type="bibr" rid="R1">1</xref>–<xref ref-type="bibr" rid="R3">3</xref>
</sup>.</p>
<p id="P3">To overcome this issue, various methods have been developed<sup>
<xref ref-type="bibr" rid="R4">4</xref>–<xref ref-type="bibr" rid="R16">16</xref>
</sup>. In particular, following the pioneer works on the application of GFP fusion techniques for membrane protein expression screening<sup>
<xref ref-type="bibr" rid="R12">12</xref>–<xref ref-type="bibr" rid="R14">14</xref>
</sup>, GFP fusion-based Fluorescence-detection Size-Exclusion Chromatography (FSEC) has been widely utilized for rapid evaluation of the expression status and thermostability of membrane proteins from both eukaryotes and prokaryotes<sup>
<xref ref-type="bibr" rid="R15">15</xref>,<xref ref-type="bibr" rid="R16">16</xref>
</sup>.</p>
<p id="P4">In GFP fusion-based FSEC, recombinantly expressed GFP-fused proteins can be detected by a fluorescence detector following size-exclusion chromatography. The resulting fluorescence chromatography profiles allow one to rapidly analyze the expression level, monodispersity, and stability of both unpurified and purified membrane proteins at a scale on the order of nanograms. GFP fusion-based FSEC, which is suited for the high-throughput screening of panels of orthologs, mutations and membrane proteins under different biochemical conditions, has been shown to be powerful in determining the structure of eukaryotic and prokaryotic membrane proteins by both cryo-EM and X-ray crystallography<sup>
<xref ref-type="bibr" rid="R17">17</xref>–<xref ref-type="bibr" rid="R25">25</xref>
</sup>.</p>
<p id="P5">Nevertheless, several significant disadvantages of this method have also been recognized.</p>
<p id="P6">First, because GFP is a highly stable, soluble protein, its fusion sometimes causes false-positive hits by FSEC screening. In the case of such false-positive hits, GFP fusion proteins exhibit monodispersity by FSEC, but target membrane proteins may immediately aggregate or precipitate after the removal of GFP due to the instability of the target membrane protein alone<sup>
<xref ref-type="bibr" rid="R26">26</xref>
</sup>. Second, in addition to the issue of false positivity, GFP fusion also causes a false negativity because it sometimes negatively affects the expression level<sup>
<xref ref-type="bibr" rid="R27">27</xref>,<xref ref-type="bibr" rid="R28">28</xref>
</sup>. Finally, depending on the membrane topology of the target membrane protein, the GFP fusion technique may be difficult to apply. For instance, GFP fusion technology is not well suited for application with bacterial membrane proteins whose both N- and C-terminal ends are located at the periplasm because GFP tends to fail to fold properly at the periplasm and thus does not show its fluorescence<sup>
<xref ref-type="bibr" rid="R29">29</xref>,<xref ref-type="bibr" rid="R30">30</xref>
</sup>. Likewise, eukaryotic Cys-loop receptors are also known to be unsuitable for either N- or C-terminal GFP fusion<sup>
<xref ref-type="bibr" rid="R31">31</xref>,<xref ref-type="bibr" rid="R32">32</xref>
</sup>. Thus, the insertion of GFP into the cytoplasmic loop is required for the application of GFP technology<sup>
<xref ref-type="bibr" rid="R31">31</xref>,<xref ref-type="bibr" rid="R32">32</xref>
</sup>. This finding indicates that the simple strategy of N- or C-terminal GFP fusion is not applicable to some eukaryotic membrane proteins; thus, the application of GFP fusion-based FSEC may need optimization of the position at which GFP is inserted.</p>
<p id="P7">To overcome such disadvantages, a GFP fusion-free FSEC method would be ideal, and a multivalent nitrilotriacetic acid (NTA) fluorescent probe called P3NTA was developed as a pioneer work of the GFP fusion-free FSEC method<sup>
<xref ref-type="bibr" rid="R9">9</xref>
</sup>. The P3NTA probe can bind the poly-histidine tag fused to a target membrane protein for detection by FSEC without the need for purification. However, since interactions of the P3NTA probe with poly-histidine-tagged proteins are relatively weak and nonspecific, endogenous proteins from host cells with multiple accessible histidine residues may seriously affect the detection of target proteins<sup>
<xref ref-type="bibr" rid="R33">33</xref>
</sup>. In particular, expression constructs of membrane proteins with high stability and monodispersity but relatively moderate expression are hard to identify from FSEC screening by P3NTA due to its relatively weak and nonspecific detection ability. However, such expression constructs would now still be promising since structure determination by cryo-EM requires much less purified protein than that by X-ray crystallography<sup>
<xref ref-type="bibr" rid="R34">34</xref>
</sup>.</p>
<p id="P8">To make further practical use of GFP fusion-free FSEC, we hypothesized that the application of other types of small peptide tags with high affinity and specificity would be ideal and that recent advances in nanobody (Nb) technologies for small peptides would meet such demands for GFP fusion-free FSEC.</p>
<p id="P9">Nb technology has been broadly utilized in laboratory research, clinical diagnosis and potential therapies<sup>
<xref ref-type="bibr" rid="R35">35</xref>
</sup>. Nbs, which are derived from the antigen-specific variable domain of the camelid heavy-chain antibody, have a molecular weight of 12-15 kDa and can be recombinantly expressed in bacteria with high yield.</p>
<p id="P10">Recently, the peptide tags ALFA and BC2 and the corresponding specific Nbs we refer to here as NbALFA and NbBC2, respectively, were developed<sup>
<xref ref-type="bibr" rid="R33">33</xref>,<xref ref-type="bibr" rid="R36">36</xref>
</sup>. The ALFA tag (SRLEEELRRRLTE), designed de novo, forms a stable, hydrophilic and electroneutral α-helix in solution with an extremely high affinity of ~26 pM for NbALFA<sup>
<xref ref-type="bibr" rid="R33">33</xref>,<xref ref-type="bibr" rid="R37">37</xref>
</sup>. The de novo designed sequence of ALFA is absent in common model organisms, which makes its recognition by NbALFA unique<sup>
<xref ref-type="bibr" rid="R33">33</xref>
</sup>. The BC2 tag (PDRKAAVSHWQQ), derived from residues 16-27 of β–catenin, is unstructured in solution, and has a high affinity of ~1.4 nM for NbBC2<sup>
<xref ref-type="bibr" rid="R36">36</xref>
</sup>.</p>
<p id="P11">Here, we developed a new type of FSEC utilizing Nb technology named FSEC-Nb. A membrane protein fused to the small peptide tag ALFA is recombinantly expressed in bacterial or eukaryotic cells. The whole-cell extracts are then solubilized and mixed with the NbALFA Nb, which is specific for the ALFA tag, fused to mEGFP<sup>
<xref ref-type="bibr" rid="R38">38</xref>
</sup> for FSEC analysis (<xref ref-type="fig" rid="F1">Fig. 1</xref>).</p>
<p id="P12">To validate the method, we applied FSEC-Nb to the expression of bacterial and eukaryotic membrane proteins and showed that FSEC-Nb can be applied to ortholog screening and a thermostability assay.</p>
<p id="P13">Notably, we applied FSEC-Nb to orthologs of the zinc-activated ion channel (ZAC) family, a member of the Cys-loop receptor superfamily, which are unsuitable for either N- or C-terminal GFP fusion, and identified a ZAC ortholog from <italic>Oryzias latipes</italic> (OlZAC). However, we were not able to detect the expression of OlZAC by P3NTA, a previously developed GFP fusion-free FSEC method. Consistent with the FSEC-Nb results, the negative staining EM and cryo-EM of the purified ZAC ortholog showed the monodispersity of the particles. Furthermore, we screened the expression of membrane proteins from SARS-CoV-2 by FSEC-Nb and identified two of them with a high level of expression and monodispersity, which could facilitate further structural and functional studies of SARS-CoV-2. Overall, our results showed FSEC-Nb as a powerful tool for expression screening of membrane proteins.</p>
</sec>
<sec id="S2" sec-type="results">
<title>Results</title>
<sec id="S3">
<title>Establishing the FSEC-Nb method</title>
<p id="P14">To overcome the disadvantages of the conventional FSEC method, we designed FSEC-Nb, which utilizes short peptides as fusion tags and Nbs specific to these peptides fused to monomerized EGFP proteins as a probe (<xref ref-type="fig" rid="F1">Fig. 1</xref>).</p>
<p id="P15">We first applied our method to a prokaryotic ortholog of Zrt/Irt-like protein (ZIP) in the <italic>E. coli</italic> expression system. ZIPs function as metal transporters and are conserved from prokaryotes to eukaryotes, including humans<sup>
<xref ref-type="bibr" rid="R39">39</xref>
</sup>. Among the ZIP family, the structure of the bacterial ZIP protein from <italic>Bordetella bronchiseptica</italic> (BbZIP) was determined by crystallography<sup>
<xref ref-type="bibr" rid="R39">39</xref>
</sup>; we chose to utilize BbZIP to establish our FSEC-Nb system because both its N- and C-terminal ends are located at the periplasm<sup>
<xref ref-type="bibr" rid="R39">39</xref>
</sup>, which is not well suited for application of the GFP fusion-based FSEC method in bacterial expression systems.</p>
<p id="P16">In our experiment, BbZIP was fused to the peptide tags ALFA and BC2 at its C-terminus and recombinantly expressed in <italic>E. coli</italic>. The whole-cell extract was solubilized with detergents and mixed with mEGFP-fused Nbs specific for either the ALFA or BC2 tag (<xref ref-type="fig" rid="F2">Fig. 2A and 2B</xref>). After removal of the pellet by ultracentrifugation, the sample was applied to a SEC column connected to a fluorescence detector (<xref ref-type="fig" rid="F1">Fig. 1</xref>). When BbZIP was probed with mEGFP-tagged NbALFA, the FSEC plots presented peaks for both the mEGFP-tagged NbALFA in complex with the ALFA peptide-tagged BbZIP and free mEGFP-tagged NbALFA (<xref ref-type="fig" rid="F2">Fig. 2A</xref>), but the corresponding complex peak was not observed when BbZIP was probed with mEGFP-tagged NbBC2 (<xref ref-type="fig" rid="F2">Fig. 2B</xref>). These results showed that mEGFP-NbALFA specifically recognized the ALFA peptide-tagged BbZIP protein for the detection of BbZIP expression. The reason for the failure of mEGFP-tagged NbBC2 and the BC2 tag is unknown but may have been due to the difference between tags in terms of their affinities for their Nbs (ALFA: ~26 pM, BC2: ~1.4 nM)<sup>
<xref ref-type="bibr" rid="R33">33</xref>,<xref ref-type="bibr" rid="R36">36</xref>
</sup>. Furthermore, we tested expression of the C-terminally mEGFP-tagged BbZIP by FSEC but did not detect its expression (<xref ref-type="fig" rid="F2">Fig. 2C</xref>), consistent with the finding that the C-terminal end of BbZIP is located at the periplasm<sup>
<xref ref-type="bibr" rid="R39">39</xref>
</sup>. We also tested expression of BbZIP C-terminally fused to muGFP<sup>
<xref ref-type="bibr" rid="R40">40</xref>
</sup>, a derivative of superfolder GFP<sup>
<xref ref-type="bibr" rid="R41">41</xref>
</sup>, since superfolder GFP is more suitable for its folding at the periplasm<sup>
<xref ref-type="bibr" rid="R42">42</xref>,<xref ref-type="bibr" rid="R43">43</xref>
</sup>. However, we still did not detect the expression of the muGFP-tagged BbZIP by FSEC (<xref ref-type="fig" rid="F2">Fig. 2C</xref>).</p>
<p id="P17">Overall, based on the results from BbZIP, we decided to employ the ALFA peptide tag and mEGFP-tagged NbALFA with our FSEC-Nb system for further experiments.</p>
</sec>
<sec id="S4">
<title>Thermostability assay by FSEC-Nb</title>
<p id="P18">We next applied the FSEC-Nb method to check membrane protein expression in mammalian cells and tested whether the FSEC-Nb system can be employed for thermostability assays of membrane proteins (<xref ref-type="fig" rid="F3">Fig. 3A and 3B</xref>). We chose the human P2×3 (hP2×3) protein, a member of the P2X receptor superfamily with known structures<sup>
<xref ref-type="bibr" rid="R44">44</xref>–<xref ref-type="bibr" rid="R46">46</xref>
</sup>.</p>
<p id="P19">ALFA-tagged hP2×3 was transiently expressed in HEK293 cells, which were solubilized for further FSEC-Nb experiments. The FSEC profiles of ALFA-tagged hP2×3 labeled with mEGFP-fused NbALFA showed peaks for both the mEGFP-fused NbALFA in complex with the ALFA-tagged hP2×3 and free mEGFP-fused NbALFA (<xref ref-type="fig" rid="F3">Fig. 3C</xref>), showing that the FSEC-Nb technique can be applied in HEK293 cells.</p>
<p id="P20">In the thermostability assay of hP2×3 by FSEC-Nb, solubilized samples were incubated at their respective temperatures for 10 minutes using a thermal cycler, and the precipitated materials were then removed by ultracentrifugation before labeling with mEGFP-tagged NbALFA (<xref ref-type="fig" rid="F3">Fig. 3A and 3B</xref>). The FSEC-Nb profiles clearly showed a thermal shift of the main peaks from the samples incubated at temperatures near and above 55 °C (<xref ref-type="fig" rid="F3">Fig. 3D</xref>), with estimates of the <italic>T</italic>
<sub>m</sub> of 56.6 °C.</p>
<p id="P21">We then tested the thermostabilizing effects of ATP on hP2×3 (<xref ref-type="fig" rid="F3">Fig. 3E</xref>). ATP is an endogenous ligand of P2X receptors that typically increases the thermostability of P2X receptors<sup>
<xref ref-type="bibr" rid="R16">16</xref>
</sup>. Consistently, in the thermostability assay carried out by FSEC-Nb, ATP showed a clear stabilizing effect, increasing the estimated <italic>T<sub>m</sub>
</italic> by 15 °C. These results showed that FSEC-Nb can be employed to assay the thermostability of membrane proteins without the need for purification steps.</p>
</sec>
<sec id="S5">
<title>Expression screening of ZAC orthologs and SARS-CoV-2 membrane proteins</title>
<p id="P22">As examples of the practical application of FSEC-Nb, we then applied FSEC-Nb to screen ZAC family proteins and membrane proteins from SARS-CoV-2 (<xref ref-type="fig" rid="F4">Fig. 4</xref> and <xref ref-type="fig" rid="F5">5</xref>). ZACs belong to the Cys-loop ligand-gated ion channel (LGIC) superfamily, which also includes nicotinic acetylcholine (nACh), 5-HT<sub>3</sub>, GABA<sub>A</sub> and glycine receptors<sup>
<xref ref-type="bibr" rid="R47">47</xref>,<xref ref-type="bibr" rid="R48">48</xref>
</sup>.</p>
<p id="P23">In addition to Zn<sup>2+</sup>, the gating of ZACs, nonselective cation channels that are widely expressed in the human body, is activated by Cu<sup>2+</sup> and protons<sup>
<xref ref-type="bibr" rid="R48">48</xref>
</sup>. Since ZACs were the last members of the Cys-loop LGIC superfamily to be discovered<sup>
<xref ref-type="bibr" rid="R47">47</xref>–<xref ref-type="bibr" rid="R49">49</xref>
</sup>, their function and structure are poorly characterized.</p>
<p id="P24">To facilitate structural and biophysical studies of ZAC proteins, we utilized FSEC-Nb to overcome the difficulty imposed by heterogeneous ZAC expression and purification. We chose to apply FSEC-Nb to ZACs because Cys-loop LGIC superfamily proteins were reported to be unsuitable for either N- or C-terminal GFP fusion<sup>
<xref ref-type="bibr" rid="R31">31</xref>,<xref ref-type="bibr" rid="R32">32</xref>
</sup>.</p>
<p id="P25">ZAC genes from <italic>Homo sapiens</italic> (HsZAC), <italic>Danio rerio</italic> (DrZAC), <italic>Oryzias latipes</italic> (OlZAC) and <italic>Oreochromis niloticus</italic> (OnZAC) were synthesized with ALFA and octa-histidine tags at the C-terminus, and recombinantly expressed in HEK293 cells. The expressed ZAC orthologs were probed by mEGFP-tagged NbALFA for detection by the FSEC-Nb method. FSEC-Nb screening of ZAC orthologs showed that the profile for OlZAC exhibited a higher and sharper peak than those for other ZAC orthologs (<xref ref-type="fig" rid="F4">Fig. 4A</xref>). In contrast, we could not detect the expression of the C-terminally muGFP-tagged OlZAC by FSEC (<xref ref-type="fig" rid="F4">Fig. 4B</xref>). Furthermore, we could not detect the expression of OlZAC by P3NTA-based FSEC, the previously developed GFP fusion-free FSEC method (<xref ref-type="fig" rid="F4">Fig. 4C</xref>), showing the improved sensitivity of FSEC-Nb over P3NTA-based FSEC.</p>
<p id="P26">SARS-CoV-2 is a pathogen that causes coronavirus disease 2019 (COVID-19)<sup>
<xref ref-type="bibr" rid="R50">50</xref>–<xref ref-type="bibr" rid="R52">52</xref>
</sup>. Using FSEC-Nb, we screened the expression of a series of membrane proteins from SARS-CoV-2 (<xref ref-type="fig" rid="F5">Fig. 5</xref>). We identified ORF3a and ORF7b with high monodispersity and high expression level, comparable to those of hP2×3 (<xref ref-type="fig" rid="F5">Fig. 5</xref>). ORF3a is an ion channel and potential target for COVID-19 therapy<sup>
<xref ref-type="bibr" rid="R53">53</xref>
</sup>. A mutation on ORF7b reportedly showed higher replicative fitness<sup>
<xref ref-type="bibr" rid="R54">54</xref>
</sup>. Consistent with the sharp peak from FSEC-Nb, the cryo-EM structure of ORF3a was recently reported on bioRxiv<sup>
<xref ref-type="bibr" rid="R53">53</xref>
</sup>. Overall, our FSEC-Nb screening results may facilitate structural and functional studies of SARS-CoV-2.</p>
</sec>
<sec id="S6">
<title>Detergent screening of OlZAC</title>
<p id="P27">Purification of membrane proteins requires detergents to extract the proteins from the biological membrane. The type of detergent used often affects the monodispersity and stability of a membrane protein in purification; thus, detergent screening is beneficial for establishing purification protocols for membrane proteins. Furthermore, the addition of lipids and lipid-like compounds, such as cholesteryl hemisuccinate (CHS), which was shown to be useful for the purification and crystallization of various GPCRs<sup>
<xref ref-type="bibr" rid="R55">55</xref>–<xref ref-type="bibr" rid="R57">57</xref>
</sup>, could also affect the stability of membrane proteins<sup>
<xref ref-type="bibr" rid="R16">16</xref>
</sup>. In our assay of OlZAC thermostability by FSEC-Nb, we tested multiple types of detergents for OlZAC; among these detergents were n-dodecyl-b-D-maltoside (DDM); DDM additive with CHS at a ratio of 5:1 (w:w), referred to as DDM-CHS; lauryl maltose neopentyl glycol (LMNG); &gt;and glyco-diosgenin (GDN). The FSEC-Nb profiles of OlZAC solubilized with DDM showed a thermal shift of the main peaks from the samples incubated at temperatures near and above 60 °C (<xref ref-type="fig" rid="F6">Fig. 6A</xref>), with estimates of the Tm of 60.6 °C (<xref ref-type="fig" rid="F6">Fig. 6B</xref>). Unpurified ALFA-tagged OlZAC samples solubilized with the respective detergents were heat-treated at 60 °C for 10 minutes, and FSEC-Nb was applied to both heated and unheated samples for comparison (<xref ref-type="fig" rid="F6">Fig. 6C</xref>). Compared to DDM, LMNG conferred better thermostability to OlZAC, whereas DDM-CHS solubilized OlZAC similarly as with DDM (<xref ref-type="fig" rid="F6">Fig. 6C</xref>). The performance of GDN was similar to that of LMNG (<xref ref-type="fig" rid="F6">Fig. 6C</xref>). Based on the results of detergent screening with OlZAC by FSEC-Nb, we decided to employ either DDM or DDM-CHS for protein extraction from the membrane and either LMNG or GDN for the subsequent purification steps.</p>
</sec>
<sec id="S7">
<title>Large-scale culture and purification of OlZAC</title>
<p id="P28">For large-scale culture in HEK293S cells, we then generated bacmid DNA for OlZAC, which was used to transfect Sf9 insect cells to prepare BacMam virus. To optimize the expression conditions, using FSEC-Nb, we performed small-scale expression screening in HEK293S cells by testing different amounts of P2 virus, incubation times, and cell culture temperatures at 16 hours after the addition of P2 virus (<xref ref-type="fig" rid="F7">Fig. 7A and 7B</xref>) and decided to choose one set of conditions for large-scale culture (1% volume P2 virus addition, 88 hours of culture at 37 °C after the addition of virus).</p>
<p id="P29">OlZAC was purified as described in the Methods section. Briefly, the membrane collected from cell lysates was solubilized in DDM-CHS, and the detergent was then exchanged to LMNG in the affinity chromatography steps. During size-exclusion chromatography in SEC buffer containing LMNG, the UV absorbance plot showed a symmetric peak for OlZAC and a prior void peak (<xref ref-type="fig" rid="F7">Fig. 7C</xref>). A total of 2.4 liters of HEK293 cell culture yielded approximately 0.5 mg of purified OlZAC protein. Trp-based FSEC verified the monodispersity of the pooled fractions constituting the main SEC peaks (<xref ref-type="fig" rid="F7">Fig. 7D</xref>), and the purity of the pooled fractions was validated by SDS-PAGE (<xref ref-type="fig" rid="F7">Fig. 7E</xref>).</p>
</sec>
<sec id="S8">
<title>Negative staining EM and cryo-EM of OlZAC</title>
<p id="P30">To evaluate the sample quality of OlZAC, which was identified by FSEC-Nb, we performed negative staining EM and preliminary cryo-EM of OlZAC (<xref ref-type="fig" rid="F8">Fig. 8</xref>).</p>
<p id="P31">Pioneering structural studies of other eukaryotic pLGIC members by crystallography and cryo-EM have elucidated their fundamental architecture: a pentamer comprised of an extracellular component for ligand gating, a transmembrane component for ion permeation and an intracellular component<sup>
<xref ref-type="bibr" rid="R32">32</xref>,<xref ref-type="bibr" rid="R58">58</xref>–<xref ref-type="bibr" rid="R64">64</xref>
</sup>. ZACs possess low amino acid sequence identity with other pLGIC members, with the closest matches exhibiting ~20% identity with ZACs<sup>
<xref ref-type="bibr" rid="R47">47</xref>,<xref ref-type="bibr" rid="R48">48</xref>
</sup>. Accordingly, little is still known about the ZAC structure.</p>
<p id="P32">The OlZAC purified under the apo conditions was reconstituted into amphipol by mixing with amphipols at a mass ratio of 1:20, and the detergent was removed by Bio-Beads. We tested the reconstitution of NAPol on a small scale by Trp-FSEC, which resulted in a high and symmetric peak for the amphipol-reconstituted OlZAC (<xref ref-type="supplementary-material" rid="SD1">Fig. S1A</xref>). NAPol is a nonionic amphipol that is soluble across a wide pH range and compatible with multivalent cations<sup>
<xref ref-type="bibr" rid="R65">65</xref>,<xref ref-type="bibr" rid="R66">66</xref>
</sup>; thus, we chose NAPol for ZACs since both pH and the presence of divalent cations are relevant to the functional status of ZACs. On a large scale, we further reconstituted OlZAC into NAPol and separated the amphipol-reconstituted OlZAC by SEC (<xref ref-type="supplementary-material" rid="SD1">Fig. S1B</xref>).</p>
<p id="P33">The amphipol-reconstituted OlZAC was then stained by uranyl acetate and observed under an electron microscope. The images taken by the EM-CCD camera showed monodispersed OlZAC particles (<xref ref-type="fig" rid="F8">Fig. 8A</xref>). Because of the high contrast after negative staining, the particles were easily recognized from the images (<xref ref-type="fig" rid="F8">Fig. 8B</xref>). The particles extracted from over one hundred images were classified into several 2D classes, which validated the stoichiometry and constitution of ZACs (<xref ref-type="fig" rid="F8">Fig. 8C, 8D and 8E</xref>). Similar to other pLGIC members, ZACs form a pentamer (<xref ref-type="fig" rid="F8">Fig. 8E</xref>) and is composed of extracellular, transmembrane and intracellular components (<xref ref-type="fig" rid="F8">Fig. 8D</xref>).</p>
<p id="P34">We then performed preliminary cryo-EM single-particle analysis of OlZAC with a K3 direct detection camera (<xref ref-type="fig" rid="F8">Fig. 8F and 8G</xref>), which also showed monodispersed particles.</p>
<p id="P35">These results showed the sample quality of OlZAC identified by FSEC-Nb, which would be suitable for structural studies.</p>
</sec>
</sec>
<sec id="S9" sec-type="discussion">
<title>Discussion</title>
<p id="P36">In this work, we developed a new type of FSEC assay, named FSEC-Nb, utilizing the ALFA peptide tag and anti-ALFA peptide Nb NbALFA. In FSEC-Nb, targeted membrane proteins are tagged by the peptide tag ALFA and recombinantly expressed in either prokaryotic or eukaryotic cells before being probed by mEGFP-tagged NbALFA for FSEC analysis (<xref ref-type="fig" rid="F1">Fig. 1</xref>). We first tested two peptide tags, ALFA and BC2, and found that the peptide tag ALFA was more suitable for the detection of BbZIP by FSEC-Nb in a bacterial expression system (<xref ref-type="fig" rid="F2">Fig. 2</xref>). We then applied the FSEC-Nb method for a thermostability assay (<xref ref-type="fig" rid="F3">Fig. 3</xref>). As a demonstration of the practical application of FSEC-Nb, we then applied FSEC-Nb for the screening of orthologs of ZAC, a member of the Cys-loop LGIC superfamily without a known 3D structure, as well as membrane proteins from SARS-CoV-2 (<xref ref-type="fig" rid="F4">Fig. 4</xref> and <xref ref-type="fig" rid="F5">5</xref>). We then further screened different types of detergents for the purification of OlZAC (<xref ref-type="fig" rid="F6">Fig. 6</xref>). Finally, using purified OlZAC (<xref ref-type="fig" rid="F7">Fig. 7</xref>), we performed negative staining EM and preliminary cryo-EM, which showed the monodispersity of the purified OlZAC sample (<xref ref-type="fig" rid="F8">Fig. 8</xref>).</p>
<p id="P37">FSEC-Nb confers the advantage of conventional GFP fusion-based FSEC but avoids the following disadvantages of GFP fusion-based FSEC.</p>
<p id="P38">First, GFP fusion-based FSEC is not well suited for some membrane proteins, depending on their membrane topology<sup>
<xref ref-type="bibr" rid="R29">29</xref>–<xref ref-type="bibr" rid="R32">32</xref>
</sup>. To be noted, the membrane topology prediction from 29 organisms by TransMembrane Hidden Markov Model (TMHMM)<sup>
<xref ref-type="bibr" rid="R67">67</xref>
</sup> showed ~20% of multispanning membrane proteins possess both their N- and C-terminal ends at the extracellular or periplasmic sides. Furthermore, even when applicable, GFP fusion may occasionally affect the expression and/or stability of targeted membrane proteins, potentially leading to both false-positive and false-negative results<sup>
<xref ref-type="bibr" rid="R26">26</xref>–<xref ref-type="bibr" rid="R28">28</xref>
</sup>. In our recent worst case, we screened over 60 homologs of MgtC, a virulence factor in <italic>Salmonella enterica</italic>
<sup>
<xref ref-type="bibr" rid="R68">68</xref>
</sup>, by GFP fusion-based FSEC with the C-terminally mGFPuv-tagged expression constructs (<xref ref-type="supplementary-material" rid="SD1">Table S1</xref>), because the C-terminal end of MgtC is located at the cytoplasm. We identified only two of them with high monodispersity and expression level (<xref ref-type="supplementary-material" rid="SD1">Fig. S2</xref>). However, both two proteins aggregated and precipitated after the removal of the GFP tag. In addition, compared to the P3-NTA method, a previously developed GFP fusion-free FSEC method utilizing poly-histidine tag, FSEC-Nb showed better performance in the screening of ZAC protein orthologs (<xref ref-type="fig" rid="F5">Fig. 5</xref>). Overall, FSEC-Nb would be useful for expression screening of both types of membrane proteins to which the conventional GFP fusion-based FSEC is applicable and is not applicable.</p>
<p id="P39">On the other hand, representing a disadvantage of our FSEC-Nb assay over the conventional GFP fusion FSEC method, purified GFP-fused NbALFA, which acts as a probe, needs to be prepared in each laboratory that wishes to use this method. However, the purification of mEGFP-fused NbALFA would be easy for most biochemistry and structural biology laboratories, as its <italic>E. coli</italic> expression level is quite high (more than 10 mg of purified protein from 1 liter of <italic>E. coli</italic> culture), and 1 mg of mEGFP-fused NbALFA is enough for 1,000 FSEC-Nb experiments and would thus last for a couple of years with conventional laboratory usage. Furthermore, to improve access for FSEC-Nb, we have deposited the expression vectors for mEGFP- and mCherry-fused NbALFAs as well as template vectors with the ALFA tag for expression in <italic>E. coli</italic> (pETNb-nALFA and pETNb-cALFA) and insect (pFBNb-cALFA) and mammalian (pBMNb-cALFA) cells to the Addgene plasmid repository (<xref ref-type="fig" rid="F9">Fig. 9</xref>). We have also deposited BbZIP gene in pETNb-cALFA and hP2×3 gene in pBMNb-cALFA as positive controls for FSEC-Nb. Thus, FSEC-Nb can be easily introduced to most biochemistry and structural biology laboratories, particularly to labs those with the experience with the conventional GFP fusion-based FSEC method, which has already been widely used. Notably, all of these vectors can be used for not only a small-scale expression check by FSEC-Nb but also large-scale protein expression.</p>
<p id="P40">Overall, FSEC-Nb can be used for expression screening and thermostability assays on a small scale with high sensitivity and specificity without the need for GFP fusion to target proteins. Such advantages of FSEC-Nb will enable us to explore further opportunities to prepare target proteins for structure determination as well as other biophysical and pharmacological studies.</p>
</sec>
<sec id="S10" sec-type="materials | methods">
<title>Materials and Methods</title>
<sec id="S11">
<title>Purification of mEGFP-tagged Nbs</title>
<p id="P41">With an interval of GSGSGS, the NbALFA sequence was fused in frame with an N-terminal His<sub>8</sub>-mEGFP affinity tag and subcloned into the pET28b vector. The protein was overexpressed in <italic>E. coli</italic> Rosetta (DE3) cells in LB medium containing 30 μg/ml kanamycin at 37 °C by induction at an OD<sub>600</sub> of ~0.5 with 0.5 mM isopropyl D-thiogalactoside (IPTG) for 16 hours at 18 °C. The <italic>E. coli</italic> cells were subsequently harvested by centrifugation (6,000 × g, 15 minutes) and resuspended in buffer A (50 mM Tris-HCl (pH 8.0), 150 mM NaCl) supplemented with 0.5 mM phenylmethylsulfonyl fluoride (PMSF). All purification steps were performed at 4 °C. The <italic>E. coli</italic> cells were then disrupted with a microfluidizer, and debris was removed by centrifugation (70,000 × g, 60 minutes). The supernatant was loaded onto equilibrated Ni-NTA resin pre-equilibrated with buffer A and mixed for 1 hour. The column was then washed with buffer A containing 30 mM imidazole, and the protein was eluted with buffer A containing 300 mM imidazole. The imidazole was removed by dialysis in buffer B (20 mM HEPES (pH 7.0), 150 mM NaCl) overnight. Finally, the purified mEGFP-tagged NbALFA was concentrated to 1 mg/ml using an Amicon Ultra 30K filter (Merck Millipore) and stored at -80 °C before use. mEGFP-tagged NbBC was similarly expressed and purified.</p>
</sec>
<sec id="S12">
<title>FSEC-Nb in the <italic>E. coli</italic> expression system</title>
<p id="P42">In the <italic>E. coli</italic> expression system, BbZIP tagged with either the ALFA or BC2 peptide at its C-terminus was synthesized and subcloned into the pET28b vector and overexpressed with a protocol similar to that for the expression of mEGFP-tagged NbALFA described above. The <italic>E. coli</italic> cell pellets from 5 ml of LB culture were suspended in 400 μl of buffer A and sonicated, and the cell debris was removed by centrifugation (20,000 × g, 10 minutes). The lysates were solubilized by mixing 500 μl of buffer A containing 2% (w:v) DDM and 0.5 mM PMSF for 1 hour, and were ultracentrifugaed (200,000 × g, 20 minutes). Unless noted, 1 μg of mEGFP-tagged NbALFA was added to the supernatant and incubated for 30 minutes. Considering the reported affinity values of NbALFA binding to an ALFA-tag (k<sub>on</sub> (M<sup>−1</sup>s<sup>−1</sup>): 3.6(±0.1) × 10<sup>5</sup>, k<sub>off</sub> (s<sup>−1</sup>): 9.4 (±0.2) × 10<sup>−6</sup>, K<sub>D</sub> 26 (±1) pM)<sup>
<xref ref-type="bibr" rid="R33">33</xref>
</sup>, 30 minutes incubation would be enough for the saturation of the binding. After centrifugation (20,000 × g, 10 minutes), 50 μl of the sample was applied to a Superdex 200 Increase 10/300 GL column (GE Healthcare) equilibrated with buffer A containing 0.05% (w:v) DDM for the FSEC assay. GFP fusion-based FSEC was performed similarly but without the labeling step with mEGFP-tagged NbALFA. In the FSEC assay, fluorescence was detected using the RF-20Axs fluorescence detector for HPLC (Shimadzu, Japan) (for mEGFP, excitation: 480 nm, emission: 512 nm) (for muGFP, excitation: 480 nm, emission: 508 nm) (for mGFPuv, excitation: 395 nm, emission: 507 nm). FSEC-Nb experiments with mEGFP-tagged NbBC2 were performed with a similar protocol.</p>
</sec>
<sec id="S13">
<title>FSEC-Nb in the HEK293 expression system</title>
<p id="P43">hP2×3, ZAC orthologs and membrane proteins from SARS-CoV-2 containing ALFA and His<sub>8</sub> tags at their C-terminus were synthesized and subcloned into a derivative of the Bac-to-Bac system vector with the CMV promoter and WPRE motif. Using 3 μl of Lipofectamine 2000 (Thermo Fisher Scientific, US), 1 μg of each plasmid was transfected into 1 ml of HEK293S cells in adherent culture at a density of 0.5 million cells/ml in DMEM supplemented with 10% FBS. Cells were incubated in a CO<sub>2</sub> incubator (37 °C, 5% CO<sub>2</sub>) for 48 hours after transfection and solubilized with 200 μl of buffer A containing 2% (w:v) DDM supplemented with 0.5 mM PMSF, 5.2 μg/ml aprotinin, 2 μg/ml leupeptin, and 1.4 μg/ml pepstatin A (all from Sigma-Aldrich) for 1 hour. After ultracentrifugation (200,000 × g, 20 minutes), 1 μg of mEGFP-tagged NbALFA or 2 μl of 0.5 μM P3NTA was added to and mixed into 100 μl of the supernatant for 30 minutes, Then, after centrifugation (20,000 × g, 10 minutes), 50 μl of the sample was applied to a Superdex 200 Increase 10/300 GL column (GE Healthcare) equilibrated with buffer A containing 0.05% (w:v) DDM for the FSEC assay. In the FSEC assay, fluorescence was detected as described above. The P3NTA peptide was prepared and used for FSEC as previously described (excitation: 480 nm, emission: 520 nm)<sup>
<xref ref-type="bibr" rid="R9">9</xref>
</sup>.</p>
</sec>
<sec id="S14">
<title>Thermostability assay by FSEC-Nb</title>
<p id="P44">ALFA peptide-tagged hP2×3 was expressed in HEK293 cells and solubilized as described above. Cells from 4 ml of culture were resuspended in 1.2 ml of buffer A (50 mM TRIS (pH 8.0), 150 mM NaCl) containing 2% DDM by the addition of either ATP at a final concentration of 1 mM (ATP-bound conditions) or 0.6 unit of apyrase (Sigma, USA) to remove endogenous ATP (apo conditions), rotated at 4 °C for 1 hour, and then ultracentrifuged (200,000 g, 10 minutes). One hundred microliters of the supernatant was dispensed into 1.5-ml Eppendorf tubes and incubated at the respective temperature for 10 minutes using either a thermal cycler or heat block bath. After ultracentrifugation (200,000 g, 10 minutes), the supernatant was mixed with 1 μg of mEGFP-tagged NbALFA and then centrifuged (20,000 g, 10 minutes). Then, 50 μl of the supernatant was applied to a Superdex 200 Increase 10/300 GL column (GE Healthcare) equilibrated with buffer A containing 0.05% (w:v) DDM for the FSEC assay. We estimated the melting curves based on the peak heights and determined the melting temperatures by fitting the melting curves to a sigmoidal dose-response equation because the melting curves based on the peak heights were known to be consistent with the melting curves based on the peak area estimated by Gaussian fitting<sup>
<xref ref-type="bibr" rid="R16">16</xref>
</sup>.</p>
</sec>
<sec id="S15">
<title>Detergent screening by FSEC-Nb</title>
<p id="P45">HEK293S cells expressing ALFA-tagged OlZAC were prepared as described above. The collected cells were solubilized in buffer A containing different types of detergents: 2% (w:v) DDM, 2% (w:v) DDM-CHS, 1% (w:v) LMNG, and 1% (w:v) GDN. FSEC-Nb and thermostability assays by FSEC-Nb were conducted as described above.</p>
</sec>
<sec id="S16">
<title>Expression and purification of OlZAC</title>
<p id="P46">OlZAC tagged with ALFA and His<sub>8</sub> was expressed in HEK293S GnTI<sup>−</sup> cells using a baculovirus-mediated gene transduction system in mammalian cells<sup>
<xref ref-type="bibr" rid="R69">69</xref>
</sup>.</p>
<p id="P47">Small-scale expression screening to determine large-scale culture conditions was performed by FSEC-Nb (<xref ref-type="fig" rid="F7">Fig. 7A and 7B</xref>). FSEC-Nb was carried out with the protocol described above. A 800-ml culture of HEK293S GnTI<sup>−</sup> cells was grown to a density of 2.5 × 10<sup>6</sup> ml<sup>−1</sup> and infected with 8 ml of P2 BacMam virus. After 16 hours of culture at 37 °C, 10 mM sodium butyrate was added, and the temperature was maintained at 37 °C for another 72 hours of culture. Then, the cells were harvested and washed with buffer A. All purification steps were performed at 4 °C. Cells were broken by sonication with protease inhibitors (1 mM PMSF, 5.2 μg/ml aprotinin, 2 μg/ml leupeptin, and 1.4 μg/ml pepstatin A, all from Sigma-Aldrich). Membrane fractions were collected by ultracentrifugation (200,000 × g, 60 minutes). The membrane was solubilized in buffer A containing 2% (w:v) DDM-CHS and supplemented with protease inhibitors (1 mM PMSF, 5.2 μg/ml aprotinin, 2 μg/ml leupeptin, and 1.4 μg/ml pepstatin A, all from Sigma-Aldrich) for 2 hours. The debris was removed by ultracentrifugation (200,000 × g, 60 minutes). The supernatant was loaded onto equilibrated TALON resin (Clontech) and then washed with buffer A containing 0.01% (w:v) LMNG and 10 mM imidazole. Protein was eluted with buffer A containing 300 mM imidazole. The eluted protein was loaded on a Superdex 200 10/300 GL column and subjected to SEC in buffer B containing 0.01% (w:v) LMNG. The main peak fractions were pooled and concentrated to ~1 mg/ml using an Amicon Ultra 100K filter (Merck Millipore).</p>
</sec>
<sec id="S17">
<title>Amphipol reconstitution</title>
<p id="P48">All steps were performed at 4 °C. On a small scale, 10 μg of OlZAC (10 μl) was mixed with 200 μg of NAPol (Anatrace, dissolved in 2 μl of buffer B) and incubated for 16 hours. The detergent was removed by incubation with Bio-Beads SM-2 (Bio-Rad) for 4 hours, after which the beads were removed over a disposable Poly-Prep column. Twenty microliters of the eluent was diluted to 200 μl, and 50 μl of the sample was applied to a Superdex 200 10/300 GL column equilibrated with buffer A for Trp-based FSEC (excitation: 280 nm, emission: 325 nm). At a large scale, 500 μg of OlZAC (500 μl) was mixed with 10 mg of NAPol (Anatrace, dissolved in 100 μl of buffer B) and incubated for 16 hours. The detergent was removed with Bio-Beads SM-2 (Bio-Rad) for 4 hours, and the beads were subsequently removed over a disposable Poly-Prep column. The eluent was applied to a Superdex 200 10/300 GL column equilibrated with buffer B, and the main fractions consisting of the amphipol-reconstituted OlZAC were pooled and concentrated to ~3 mg/ml using an Amicon Ultra 100K filter for electron microscopic analysis.</p>
</sec>
<sec id="S18">
<title>Negative staining and electron microscopy</title>
<p id="P49">Gilder 400 square mesh grids (AG400) were glow discharged in a PELCO easiGlow apparatus at a current of 25 mA for 30 seconds. Five microliters of protein solution (~20 μg/mL) was dropped onto the grid and allowed to remain on the grid for 1 minute. The residual protein solution was blotted from the grid edge with a piece of filter paper. The grid was covered with 2% uranyl acetate, blotted immediately, covered again with 2% uranyl acetate for 30 seconds and blotted again. After drying, the grid was observed under a Talos L120C microscope at 120 kV. In total, 133 micrographs were taken with a Ceta CCD camera at a nominal magnification of 92,000× at a pixel size of 1.55 Å. The micrographs were processed in RELION 3.0 for particle picking, extraction and 2D classification<sup>
<xref ref-type="bibr" rid="R70">70</xref>
</sup>.</p>
</sec>
<sec id="S19">
<title>Cryo-EM data acquisition</title>
<p id="P50">A total of 2.5 μl of OlZAC in NAPol was applied to a glow-discharged holey carbon film grid (QUANTIFOIL, R1.2/1.3, 100 Holey Carbon Films, Au 300 mesh) blotted with a Vitrobot (FEI) system using a 3.0-s blotting time with 100% humidity at 9 °C and plunge-frozen in liquid ethane. Cryo-EM images were collected on a Titan Krios (FEI) electron microscope operated at an acceleration voltage of 300 kV. The specimen stage temperature was maintained at 80 K. Images were recorded with a K3 Summit direct electron detector camera (Gatan Inc.) set to super-resolution mode with a pixel size of 0.41 Å (a physical pixel size of 0.82 Å) and a defocus ranging from -1.3 μm to -2.0 μm. The dose rate was 20 e<sup>−</sup> s<sup>–1</sup>, and each movie was 1.76 seconds long, dose-fractioned into 40 frames, with an exposure of 1.3 e<sup>−</sup> Å<sup>–2</sup> for each frame.</p>
</sec>
<sec id="S20">
<title>Gene synthesis</title>
<p id="P51">The gene fragments for mEGFP, muGFP, mCherry, ALFA and BC2 tags, NbALFA, NbBC2, BbZIP, ZAC, hP2×3, and membrane proteins from SARS-CoV-2 used for this research were synthesized by Genewiz (Suzhou, China).</p>
</sec>
</sec>
<sec sec-type="supplementary-material" id="SM">
<title>Supplementary Material</title>
<supplementary-material content-type="local-data" id="SD1">
<label>Supplementary Material</label>
<media xlink:href="EMS96494-supplement-Supplementary_Material.pdf" mimetype="application" mime-subtype="pdf" id="N66748" position="anchor"/>
</supplementary-material>
</sec>
</body>
<back>
<ack id="S21">
<title>Acknowledgments</title>
<p>We thank the staff scientists at the Center for Biological Imaging, Institute of Biophysics, and National Center for Protein Science Shanghai (Chinese Academy of Sciences) for technical support with cryo-EM data collection (project numbers: CBIapp201907006, CBIapp202001013 and 2019-NFPS-PT-004226) and Dr. Hideaki E. Kato (University of Tokyo) and Dr. Chia-Hsueh Lee (St. Jude Children's Research Hospital) for critical comments on the manuscript. This work was supported by funding from the Ministry of Science and Technology of China (2016YFA0502800) to M.H. and from the National Natural Science Foundation of China (project 31850410466) to M.H. This work was also supported by the Shanghai Key Laboratory of Bioactive Small Molecules (ZDSYS14005) and the Innovative Research Team of High-Level Local University in Shanghai.</p>
</ack>
<sec id="S22">
<title>Data availability</title>
<p id="P52">All data and materials are available from the authors upon reasonable request. The plasmids shown in <xref ref-type="fig" rid="F9">Fig. 9</xref> (mEGFP-NbALFA, mCherry-NbALFA, pETNb-nALFA, pETNb-cALFA, pFBNb-cALFA, pBMNb-cALFA) have been deposited into Addgene (<ext-link ext-link-type="uri" xlink:href="http://www.addgene.org/">http://www.addgene.org/</ext-link>) (Addgene IDs: 159986, 159987, 159988, 159989, 159990 and 159991). We have also deposited BbZIP gene in pETNb-cALFA and hP2×3 gene in pBMNb-cALFA as positive controls for FSEC-Nb (Addgene IDs 160498 and 160499).</p>
</sec>
<fn-group>
<fn id="FN1" fn-type="con">
<p id="P53">
<bold>Author contributions</bold>
</p>
<p id="P54">F.J. performed experiments with assistance from S.S., M.W. and Y.W. F.J. and M.H. wrote the manuscript. M.H. supervised the research. All authors discussed the manuscript.</p>
</fn>
<fn id="FN2" fn-type="conflict">
<p id="P55">
<bold>Competing interests</bold>
</p>
<p id="P56">The authors declare no competing interests.</p>
</fn>
</fn-group>
<ref-list>
<ref id="R1">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pandey</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Shin</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Patterson</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>XQ</given-names>
</name>
<name>
<surname>Rainey</surname>
<given-names>JK</given-names>
</name>
</person-group>
<article-title>Current strategies for protein production and purification enabling membrane protein structural biology</article-title>
<source>Biochem Cell Biol</source>
<year>2016</year>
<volume>94</volume>
<fpage>507</fpage>
<lpage>527</lpage>
<pub-id pub-id-type="doi">10.1139/bcb-2015-0143</pub-id>
</element-citation>
</ref>
<ref id="R2">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grisshammer</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Understanding recombinant expression of membrane proteins</article-title>
<source>Curr Opin Biotechnol</source>
<year>2006</year>
<volume>17</volume>
<fpage>337</fpage>
<lpage>340</lpage>
<pub-id pub-id-type="doi">10.1016/j.copbio.2006.06.001</pub-id>
</element-citation>
</ref>
<ref id="R3">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bill</surname>
<given-names>RM</given-names>
</name>
<etal/>
</person-group>
<article-title>Overcoming barriers to membrane protein structure determination</article-title>
<source>Nature biotechnology</source>
<year>2011</year>
<volume>29</volume>
<fpage>335</fpage>
<lpage>340</lpage>
<pub-id pub-id-type="doi">10.1038/nbt.1833</pub-id>
</element-citation>
</ref>
<ref id="R4">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alexandrov</surname>
<given-names>AI</given-names>
</name>
<name>
<surname>Mileni</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chien</surname>
<given-names>EY</given-names>
</name>
<name>
<surname>Hanson</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Stevens</surname>
<given-names>RC</given-names>
</name>
</person-group>
<article-title>Microscale fluorescent thermal stability assay for membrane proteins</article-title>
<source>Structure</source>
<year>2008</year>
<volume>16</volume>
<fpage>351</fpage>
<lpage>359</lpage>
<pub-id pub-id-type="doi">10.1016/j.str.2008.02.004</pub-id>
</element-citation>
</ref>
<ref id="R5">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mancusso</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Karpowich</surname>
<given-names>NK</given-names>
</name>
<name>
<surname>Czyzewski</surname>
<given-names>BK</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>DN</given-names>
</name>
</person-group>
<article-title>Simple screening method for improving membrane protein thermostability</article-title>
<source>Methods</source>
<year>2011</year>
<volume>55</volume>
<fpage>324</fpage>
<lpage>329</lpage>
<pub-id pub-id-type="doi">10.1016/j.ymeth.2011.07.008</pub-id>
</element-citation>
</ref>
<ref id="R6">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kotov</surname>
<given-names>V</given-names>
</name>
<etal/>
</person-group>
<article-title>High-throughput stability screening for detergent-solubilized membrane proteins</article-title>
<source>Sci Rep</source>
<year>2019</year>
<volume>9</volume>
<fpage>10379</fpage>
<pub-id pub-id-type="doi">10.1038/s41598-019-46686-8</pub-id>
</element-citation>
</ref>
<ref id="R7">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nji</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Chatzikyriakidou</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Landreh</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Drew</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>An engineered thermal-shift screen reveals specific lipid preferences of eukaryotic and prokaryotic membrane proteins</article-title>
<source>Nat Commun</source>
<year>2018</year>
<volume>9</volume>
<fpage>4253</fpage>
<pub-id pub-id-type="doi">10.1038/s41467-018-06702-3</pub-id>
</element-citation>
</ref>
<ref id="R8">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parcej</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Guntrum</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hinz</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Tampe</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Multicolour fluorescence-detection size-exclusion chromatography for structural genomics of membrane multiprotein complexes</article-title>
<source>PLoS One</source>
<year>2013</year>
<volume>8</volume>
<fpage>e67112</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0067112</pub-id>
</element-citation>
</ref>
<ref id="R9">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Backmark</surname>
<given-names>AE</given-names>
</name>
<etal/>
</person-group>
<article-title>Fluorescent probe for high-throughput screening of membrane protein expression</article-title>
<source>Protein Sci</source>
<year>2013</year>
<volume>22</volume>
<fpage>1124</fpage>
<lpage>1132</lpage>
<pub-id pub-id-type="doi">10.1002/pro.2297</pub-id>
</element-citation>
</ref>
<ref id="R10">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morales-Perez</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Noviello</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Hibbs</surname>
<given-names>RE</given-names>
</name>
</person-group>
<article-title>Manipulation of Subunit Stoichiometry in Heteromeric Membrane Proteins</article-title>
<source>Structure</source>
<year>2016</year>
<volume>24</volume>
<fpage>797</fpage>
<lpage>805</lpage>
<pub-id pub-id-type="doi">10.1016/j.str.2016.03.004</pub-id>
</element-citation>
</ref>
<ref id="R11">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yao</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Thermostabilization of Membrane Proteins by Consensus Mutation: A Case Study for a Fungal Δ8-7 Sterol Isomerase</article-title>
<source>Journal of molecular biology</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1016/j.jmb.2020.02.015</pub-id>
</element-citation>
</ref>
<ref id="R12">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Drew</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Lerch</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kunji</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Slotboom</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>de Gier</surname>
<given-names>JW</given-names>
</name>
</person-group>
<article-title>Optimization of membrane protein overexpression and purification using GFP fusions</article-title>
<source>Nat Methods</source>
<year>2006</year>
<volume>3</volume>
<fpage>303</fpage>
<lpage>313</lpage>
<pub-id pub-id-type="doi">10.1038/nmeth0406-303</pub-id>
</element-citation>
</ref>
<ref id="R13">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Drew</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group>
<article-title>A scalable, GFP-based pipeline for membrane protein overexpression screening and purification</article-title>
<source>Protein science : a publication of the Protein Society</source>
<year>2005</year>
<volume>14</volume>
<fpage>2011</fpage>
<lpage>2017</lpage>
<pub-id pub-id-type="doi">10.1110/ps.051466205</pub-id>
</element-citation>
</ref>
<ref id="R14">
<label>14</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Drew</surname>
<given-names>DE</given-names>
</name>
<name>
<surname>von Heijne</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Nordlund</surname>
<given-names>P</given-names>
</name>
<name>
<surname>de Gier</surname>
<given-names>JW</given-names>
</name>
</person-group>
<article-title>Green fluorescent protein as an indicator to monitor membrane protein overexpression in Escherichia coli</article-title>
<source>FEBS letters</source>
<year>2001</year>
<volume>507</volume>
<fpage>220</fpage>
<lpage>224</lpage>
<pub-id pub-id-type="doi">10.1016/s0014-5793(01)02980-5</pub-id>
</element-citation>
</ref>
<ref id="R15">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kawate</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Gouaux</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Fluorescence-detection size-exclusion chromatography for precrystallization screening of integral membrane proteins</article-title>
<source>Structure</source>
<year>2006</year>
<volume>14</volume>
<fpage>673</fpage>
<lpage>681</lpage>
<pub-id pub-id-type="doi">10.1016/j.str.2006.01.013</pub-id>
</element-citation>
</ref>
<ref id="R16">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hattori</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hibbs</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Gouaux</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>A fluorescence-detection size-exclusion chromatography-based thermostability assay for membrane protein precrystallization screening</article-title>
<source>Structure</source>
<year>2012</year>
<volume>20</volume>
<fpage>1293</fpage>
<lpage>1299</lpage>
<pub-id pub-id-type="doi">10.1016/j.str.2012.06.009</pub-id>
</element-citation>
</ref>
<ref id="R17">
<label>17</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamashita</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Kawate</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Gouaux</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Crystal structure of a bacterial homologue of Na<sup>+</sup>/Cl<sup>−</sup>-dependent neurotransmitter transporters</article-title>
<source>Nature</source>
<year>2005</year>
<volume>437</volume>
<fpage>215</fpage>
<lpage>223</lpage>
<pub-id pub-id-type="doi">10.1038/nature03978</pub-id>
</element-citation>
</ref>
<ref id="R18">
<label>18</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jasti</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Furukawa</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Gonzales</surname>
<given-names>EB</given-names>
</name>
<name>
<surname>Gouaux</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Structure of acid-sensing ion channel 1 at 1.9 A resolution and low pH</article-title>
<source>Nature</source>
<year>2007</year>
<volume>449</volume>
<fpage>316</fpage>
<lpage>323</lpage>
<pub-id pub-id-type="doi">10.1038/nature06163</pub-id>
</element-citation>
</ref>
<ref id="R19">
<label>19</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kawate</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Michel</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Birdsong</surname>
<given-names>WT</given-names>
</name>
<name>
<surname>Gouaux</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Crystal structure of the ATP-gated P2X4 ion channel in the closed state</article-title>
<source>Nature</source>
<year>2009</year>
<volume>460</volume>
<fpage>592</fpage>
<lpage>598</lpage>
<pub-id pub-id-type="doi">10.1038/nature08198</pub-id>
</element-citation>
</ref>
<ref id="R20">
<label>20</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sobolevsky</surname>
<given-names>AI</given-names>
</name>
<name>
<surname>Rosconi</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Gouaux</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor</article-title>
<year>2009</year>
<volume>462</volume>
<fpage>745</fpage>
<lpage>756</lpage>
<pub-id pub-id-type="doi">10.1038/nature08624</pub-id>
</element-citation>
</ref>
<ref id="R21">
<label>21</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shaffer</surname>
<given-names>PL</given-names>
</name>
<name>
<surname>Goehring</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Shankaranarayanan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gouaux</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Structure and mechanism of a Na<sup>+</sup>-independent amino acid transporter</article-title>
<source>Science</source>
<year>2009</year>
<volume>325</volume>
<fpage>1010</fpage>
<lpage>1014</lpage>
<pub-id pub-id-type="doi">10.1126/science.1176088</pub-id>
</element-citation>
</ref>
<ref id="R22">
<label>22</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Penmatsa</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>KH</given-names>
</name>
<name>
<surname>Gouaux</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>X-ray structure of dopamine transporter elucidates antidepressant mechanism</article-title>
<source>Nature</source>
<year>2013</year>
<volume>503</volume>
<fpage>85</fpage>
<lpage>90</lpage>
<pub-id pub-id-type="doi">10.1038/nature12533</pub-id>
</element-citation>
</ref>
<ref id="R23">
<label>23</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>CH</given-names>
</name>
<etal/>
</person-group>
<article-title>NMDA receptor structures reveal subunit arrangement and pore architecture</article-title>
<source>Nature</source>
<year>2014</year>
<volume>511</volume>
<fpage>191</fpage>
<lpage>197</lpage>
<pub-id pub-id-type="doi">10.1038/nature13548</pub-id>
</element-citation>
</ref>
<ref id="R24">
<label>24</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coleman</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Gouaux</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>X-ray structures and mechanism of the human serotonin transporter</article-title>
<source>Nature</source>
<year>2016</year>
<volume>532</volume>
<fpage>334</fpage>
<lpage>339</lpage>
<pub-id pub-id-type="doi">10.1038/nature17629</pub-id>
</element-citation>
</ref>
<ref id="R25">
<label>25</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Goehring</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gouaux</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Cryo-EM structures of the triheteromeric NMDA receptor and its allosteric modulation</article-title>
<source>Science</source>
<year>2017</year>
<volume>355</volume>
<pub-id pub-id-type="doi">10.1126/science.aal3729</pub-id>
</element-citation>
</ref>
<ref id="R26">
<label>26</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Drew</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group>
<article-title>GFP-based optimization scheme for the overexpression and purification of eukaryotic membrane proteins in Saccharomyces cerevisiae</article-title>
<source>Nature protocols</source>
<year>2008</year>
<volume>3</volume>
<fpage>784</fpage>
<lpage>798</lpage>
<pub-id pub-id-type="doi">10.1038/nprot.2008.44</pub-id>
</element-citation>
</ref>
<ref id="R27">
<label>27</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hsieh</surname>
<given-names>JM</given-names>
</name>
<etal/>
</person-group>
<article-title>Bridging the gap: a GFP-based strategy for overexpression and purification of membrane proteins with intra and extracellular C-termini</article-title>
<source>Protein Sci</source>
<year>2010</year>
<volume>19</volume>
<fpage>868</fpage>
<lpage>880</lpage>
<pub-id pub-id-type="doi">10.1002/pro.365</pub-id>
</element-citation>
</ref>
<ref id="R28">
<label>28</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hammon</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Palanivelu</surname>
<given-names>DV</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Minor</surname>
<given-names>DL</given-names>
<suffix>Jr</suffix>
</name>
</person-group>
<article-title>A green fluorescent protein screen for identification of well-expressed membrane proteins from a cohort of extremophilic organisms</article-title>
<source>Protein Sci</source>
<year>2009</year>
<volume>18</volume>
<fpage>121</fpage>
<lpage>133</lpage>
<pub-id pub-id-type="doi">10.1002/pro.18</pub-id>
</element-citation>
</ref>
<ref id="R29">
<label>29</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feilmeier</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Iseminger</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Schroeder</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Webber</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Phillips</surname>
<given-names>GJ</given-names>
</name>
</person-group>
<article-title>Green fluorescent protein functions as a reporter for protein localization in Escherichia coli</article-title>
<source>J Bacteriol</source>
<year>2000</year>
<volume>182</volume>
<fpage>4068</fpage>
<lpage>4076</lpage>
<pub-id pub-id-type="doi">10.1128/jb.182.14.4068-4076.2000</pub-id>
</element-citation>
</ref>
<ref id="R30">
<label>30</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Daley</surname>
<given-names>DO</given-names>
</name>
<etal/>
</person-group>
<article-title>Global topology analysis of the Escherichia coli inner membrane proteome</article-title>
<source>Science</source>
<year>2005</year>
<volume>308</volume>
<fpage>1321</fpage>
<lpage>1323</lpage>
<pub-id pub-id-type="doi">10.1126/science.1109730</pub-id>
</element-citation>
</ref>
<ref id="R31">
<label>31</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gensler</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>
<article-title>Assembly and clustering of acetylcholine receptors containing GFP-tagged epsilon or gamma subunits: selective targeting to the neuromuscular junction in vivo</article-title>
<source>Eur J Biochem</source>
<year>2001</year>
<volume>268</volume>
<fpage>2209</fpage>
<lpage>2217</lpage>
<pub-id pub-id-type="doi">10.1046/j.1432-1327.2001.02093.x</pub-id>
</element-citation>
</ref>
<ref id="R32">
<label>32</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hibbs</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Gouaux</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Principles of activation and permeation in an anion-selective Cys-loop receptor</article-title>
<source>Nature</source>
<year>2011</year>
<volume>474</volume>
<fpage>54</fpage>
<lpage>60</lpage>
<pub-id pub-id-type="doi">10.1038/nature10139</pub-id>
</element-citation>
</ref>
<ref id="R33">
<label>33</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gotzke</surname>
<given-names>H</given-names>
</name>
<etal/>
</person-group>
<article-title>The ALFA-tag is a highly versatile tool for nanobody-based bioscience applications</article-title>
<source>Nat Commun</source>
<year>2019</year>
<volume>10</volume>
<fpage>4403</fpage>
<pub-id pub-id-type="doi">10.1038/s41467-019-12301-7</pub-id>
</element-citation>
</ref>
<ref id="R34">
<label>34</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nogales</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Scheres</surname>
<given-names>SH</given-names>
</name>
</person-group>
<article-title>Cryo-EM: A Unique Tool for the Visualization of Macromolecular Complexity</article-title>
<source>Mol Cell</source>
<year>2015</year>
<volume>58</volume>
<fpage>677</fpage>
<lpage>689</lpage>
<pub-id pub-id-type="doi">10.1016/j.molcel.2015.02.019</pub-id>
</element-citation>
</ref>
<ref id="R35">
<label>35</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muyldermans</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Nanobodies: natural single-domain antibodies</article-title>
<source>Annu Rev Biochem</source>
<year>2013</year>
<volume>82</volume>
<fpage>775</fpage>
<lpage>797</lpage>
<pub-id pub-id-type="doi">10.1146/annurev-biochem-063011-092449</pub-id>
</element-citation>
</ref>
<ref id="R36">
<label>36</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Braun</surname>
<given-names>MB</given-names>
</name>
<etal/>
</person-group>
<article-title>Peptides in headlock--a novel high-affinity and versatile peptide-binding nanobody for proteomics and microscopy</article-title>
<source>Sci Rep</source>
<year>2016</year>
<volume>6</volume>
<fpage>19211</fpage>
<pub-id pub-id-type="doi">10.1038/srep19211</pub-id>
</element-citation>
</ref>
<ref id="R37">
<label>37</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Petukhov</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>
<article-title>Design of stable alpha-helices using global sequence optimization</article-title>
<source>J Pept Sci</source>
<year>2009</year>
<volume>15</volume>
<fpage>359</fpage>
<lpage>365</lpage>
<pub-id pub-id-type="doi">10.1002/psc.1122</pub-id>
</element-citation>
</ref>
<ref id="R38">
<label>38</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zacharias</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Violin</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Newton</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Tsien</surname>
<given-names>RY</given-names>
</name>
</person-group>
<article-title>Partitioning of lipid-modified monomeric GFPs into membrane microdomains of live cells</article-title>
<source>Science</source>
<year>2002</year>
<volume>296</volume>
<fpage>913</fpage>
<lpage>916</lpage>
<pub-id pub-id-type="doi">10.1126/science.1068539</pub-id>
</element-citation>
</ref>
<ref id="R39">
<label>39</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>T</given-names>
</name>
<etal/>
</person-group>
<article-title>Crystal structures of a ZIP zinc transporter reveal a binuclear metal center in the transport pathway</article-title>
<source>Sci Adv</source>
<year>2017</year>
<volume>3</volume>
<fpage>e1700344</fpage>
<pub-id pub-id-type="doi">10.1126/sciadv.1700344</pub-id>
</element-citation>
</ref>
<ref id="R40">
<label>40</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scott</surname>
<given-names>DJ</given-names>
</name>
<etal/>
</person-group>
<article-title>A Novel Ultra-Stable, Monomeric Green Fluorescent Protein For Direct Volumetric Imaging of Whole Organs Using CLARITY</article-title>
<source>Scientific reports</source>
<year>2018</year>
<volume>8</volume>
<fpage>667</fpage>
<pub-id pub-id-type="doi">10.1038/s41598-017-18045-y</pub-id>
</element-citation>
</ref>
<ref id="R41">
<label>41</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pédelacq</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Cabantous</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tran</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Terwilliger</surname>
<given-names>TC</given-names>
</name>
<name>
<surname>Waldo</surname>
<given-names>GS</given-names>
</name>
</person-group>
<article-title>Engineering and characterization of a superfolder green fluorescent protein</article-title>
<source>Nature biotechnology</source>
<year>2006</year>
<volume>24</volume>
<fpage>79</fpage>
<lpage>88</lpage>
<pub-id pub-id-type="doi">10.1038/nbt1172</pub-id>
</element-citation>
</ref>
<ref id="R42">
<label>42</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dinh</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Bernhardt</surname>
<given-names>TG</given-names>
</name>
</person-group>
<article-title>Using superfolder green fluorescent protein for periplasmic protein localization studies</article-title>
<source>J Bacteriol</source>
<year>2011</year>
<volume>193</volume>
<fpage>4984</fpage>
<lpage>4987</lpage>
<pub-id pub-id-type="doi">10.1128/jb.00315-11</pub-id>
</element-citation>
</ref>
<ref id="R43">
<label>43</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dammeyer</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Tinnefeld</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Engineered fluorescent proteins illuminate the bacterial periplasm</article-title>
<source>Computational and structural biotechnology journal</source>
<year>2012</year>
<volume>3</volume>
<fpage>e201210013</fpage>
<pub-id pub-id-type="doi">10.5936/csbj.201210013</pub-id>
</element-citation>
</ref>
<ref id="R44">
<label>44</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>
<article-title>Molecular mechanisms of human P2X3 receptor channel activation and modulation by divalent cation bound ATP</article-title>
<source>Elife</source>
<year>2019</year>
<volume>8</volume>
<pub-id pub-id-type="doi">10.7554/eLife.47060</pub-id>
</element-citation>
</ref>
<ref id="R45">
<label>45</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mansoor</surname>
<given-names>SE</given-names>
</name>
<etal/>
</person-group>
<article-title>X-ray structures define human P2X3 receptor gating cycle and antagonist action</article-title>
<source>Nature</source>
<year>2016</year>
<volume>538</volume>
<fpage>66</fpage>
<lpage>71</lpage>
<pub-id pub-id-type="doi">10.1038/nature19367</pub-id>
</element-citation>
</ref>
<ref id="R46">
<label>46</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>
<article-title>Druggable negative allosteric site of P2X3 receptors</article-title>
<source>Proc Natl Acad Sci U S A</source>
<year>2018</year>
<volume>115</volume>
<fpage>4939</fpage>
<lpage>4944</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1800907115</pub-id>
</element-citation>
</ref>
<ref id="R47">
<label>47</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davies</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Hales</surname>
<given-names>TG</given-names>
</name>
<name>
<surname>Kirkness</surname>
<given-names>EF</given-names>
</name>
</person-group>
<article-title>A novel class of ligand-gated ion channel is activated by Zn<sup>2+</sup>
</article-title>
<source>J Biol Chem</source>
<year>2003</year>
<volume>278</volume>
<fpage>712</fpage>
<lpage>717</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M208814200</pub-id>
</element-citation>
</ref>
<ref id="R48">
<label>48</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trattnig</surname>
<given-names>SM</given-names>
</name>
<etal/>
</person-group>
<article-title>Copper and protons directly activate the zinc-activated channel</article-title>
<source>Biochem Pharmacol</source>
<year>2016</year>
<volume>103</volume>
<fpage>109</fpage>
<lpage>117</lpage>
<pub-id pub-id-type="doi">10.1016/j.bcp.2016.02.004</pub-id>
</element-citation>
</ref>
<ref id="R49">
<label>49</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Houtani</surname>
<given-names>T</given-names>
</name>
<etal/>
</person-group>
<article-title>Cloning and expression of ligand-gated ion-channel receptor L2 in central nervous system</article-title>
<source>Biochem Biophys Res Commun</source>
<year>2005</year>
<volume>335</volume>
<fpage>277</fpage>
<lpage>285</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbrc.2005.07.079</pub-id>
</element-citation>
</ref>
<ref id="R50">
<label>50</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>F</given-names>
</name>
<etal/>
</person-group>
<article-title>A new coronavirus associated with human respiratory disease in China</article-title>
<source>Nature</source>
<year>2020</year>
<volume>579</volume>
<fpage>265</fpage>
<lpage>269</lpage>
<pub-id pub-id-type="doi">10.1038/s41586-020-2008-3</pub-id>
</element-citation>
</ref>
<ref id="R51">
<label>51</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Horby</surname>
<given-names>PW</given-names>
</name>
<name>
<surname>Hayden</surname>
<given-names>FG</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>GF</given-names>
</name>
</person-group>
<article-title>A novel coronavirus outbreak of global health concern</article-title>
<source>Lancet (London, England)</source>
<year>2020</year>
<volume>395</volume>
<fpage>470</fpage>
<lpage>473</lpage>
<pub-id pub-id-type="doi">10.1016/s0140-6736(20)30185-9</pub-id>
</element-citation>
</ref>
<ref id="R52">
<label>52</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>N</given-names>
</name>
<etal/>
</person-group>
<article-title>A Novel Coronavirus from Patients with Pneumonia in China, 2019</article-title>
<source>The New England journal of medicine</source>
<year>2020</year>
<volume>382</volume>
<fpage>727</fpage>
<lpage>733</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMoa2001017</pub-id>
</element-citation>
</ref>
<ref id="R53">
<label>53</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kern</surname>
<given-names>DM</given-names>
</name>
<etal/>
</person-group>
<article-title>Cryo-EM structure of the SARS-CoV-2 3a ion channel in lipid nanodiscs</article-title>
<source>bioRxiv : the preprint server for biology</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1101/2020.06.17.156554</pub-id>
</element-citation>
</ref>
<ref id="R54">
<label>54</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Su</surname>
<given-names>YCF</given-names>
</name>
<etal/>
</person-group>
<article-title>Discovery and Genomic Characterization of a 382-Nucleotide Deletion in ORF7b and ORF8 during the Early Evolution of SARS-CoV-2</article-title>
<source>mBio</source>
<year>2020</year>
<volume>11</volume>
<pub-id pub-id-type="doi">10.1128/mBio.01610-20</pub-id>
</element-citation>
</ref>
<ref id="R55">
<label>55</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cherezov</surname>
<given-names>V</given-names>
</name>
<etal/>
</person-group>
<article-title>High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor</article-title>
<source>Science</source>
<year>2007</year>
<volume>318</volume>
<fpage>1258</fpage>
<lpage>1265</lpage>
<pub-id pub-id-type="doi">10.1126/science.1150577</pub-id>
</element-citation>
</ref>
<ref id="R56">
<label>56</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rasmussen</surname>
<given-names>SG</given-names>
</name>
<etal/>
</person-group>
<article-title>Structure of a nanobody-stabilized active state of the beta2 adrenoceptor</article-title>
<source>Nature</source>
<year>2011</year>
<volume>469</volume>
<fpage>175</fpage>
<lpage>180</lpage>
<pub-id pub-id-type="doi">10.1038/nature09648</pub-id>
</element-citation>
</ref>
<ref id="R57">
<label>57</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rosenbaum</surname>
<given-names>DM</given-names>
</name>
<etal/>
</person-group>
<article-title>Structure and function of an irreversible agonist-beta2 adrenoceptor complex</article-title>
<source>Nature</source>
<year>2011</year>
<volume>469</volume>
<fpage>236</fpage>
<lpage>240</lpage>
<pub-id pub-id-type="doi">10.1038/nature09665</pub-id>
</element-citation>
</ref>
<ref id="R58">
<label>58</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miller</surname>
<given-names>PS</given-names>
</name>
<name>
<surname>Aricescu</surname>
<given-names>AR</given-names>
</name>
</person-group>
<article-title>Crystal structure of a human GABAA receptor</article-title>
<source>Nature</source>
<year>2014</year>
<volume>512</volume>
<fpage>270</fpage>
<lpage>275</lpage>
<pub-id pub-id-type="doi">10.1038/nature13293</pub-id>
</element-citation>
</ref>
<ref id="R59">
<label>59</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Michelsen</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Schneider</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Shaffer</surname>
<given-names>PL</given-names>
</name>
</person-group>
<article-title>Crystal structure of human glycine receptor-alpha3 bound to antagonist strychnine</article-title>
<source>Nature</source>
<year>2015</year>
<volume>526</volume>
<fpage>277</fpage>
<lpage>280</lpage>
<pub-id pub-id-type="doi">10.1038/nature14972</pub-id>
</element-citation>
</ref>
<ref id="R60">
<label>60</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Du</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Gouaux</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Glycine receptor mechanism elucidated by electron cryo-microscopy</article-title>
<source>Nature</source>
<year>2015</year>
<volume>526</volume>
<fpage>224</fpage>
<lpage>229</lpage>
<pub-id pub-id-type="doi">10.1038/nature14853</pub-id>
</element-citation>
</ref>
<ref id="R61">
<label>61</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Basak</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>
<article-title>Cryo-EM structure of 5-HT3A receptor in its resting conformation</article-title>
<source>Nat Commun</source>
<year>2018</year>
<volume>9</volume>
<fpage>514</fpage>
<pub-id pub-id-type="doi">10.1038/s41467-018-02997-4</pub-id>
</element-citation>
</ref>
<ref id="R62">
<label>62</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walsh</surname>
<given-names>RM</given-names>
<suffix>Jr</suffix>
</name>
<etal/>
</person-group>
<article-title>Structural principles of distinct assemblies of the human alpha4beta2 nicotinic receptor</article-title>
<source>Nature</source>
<year>2018</year>
<volume>557</volume>
<fpage>261</fpage>
<lpage>265</lpage>
<pub-id pub-id-type="doi">10.1038/s41586-018-0081-7</pub-id>
</element-citation>
</ref>
<ref id="R63">
<label>63</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Phulera</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>
<article-title>Cryo-EM structure of the benzodiazepine-sensitive alpha1beta1gamma2S tri-heteromeric GABAA receptor in complex with GABA</article-title>
<source>Elife</source>
<year>2018</year>
<volume>7</volume>
<pub-id pub-id-type="doi">10.7554/eLife.39383</pub-id>
</element-citation>
</ref>
<ref id="R64">
<label>64</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miyazawa</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Fujiyoshi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Unwin</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Structure and gating mechanism of the acetylcholine receptor pore</article-title>
<source>Nature</source>
<year>2003</year>
<volume>423</volume>
<fpage>949</fpage>
<lpage>955</lpage>
<pub-id pub-id-type="doi">10.1038/nature01748</pub-id>
</element-citation>
</ref>
<ref id="R65">
<label>65</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharma</surname>
<given-names>KS</given-names>
</name>
<etal/>
</person-group>
<article-title>Non-ionic amphiphilic homopolymers: synthesis, solution properties, and biochemical validation</article-title>
<source>Langmuir</source>
<year>2012</year>
<volume>28</volume>
<fpage>4625</fpage>
<lpage>4639</lpage>
<pub-id pub-id-type="doi">10.1021/la205026r</pub-id>
</element-citation>
</ref>
<ref id="R66">
<label>66</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bazzacco</surname>
<given-names>P</given-names>
</name>
<etal/>
</person-group>
<article-title>Nonionic homopolymeric amphipols: application to membrane protein folding, cell-free synthesis, and solution nuclear magnetic resonance</article-title>
<source>Biochemistry</source>
<year>2012</year>
<volume>51</volume>
<fpage>1416</fpage>
<lpage>1430</lpage>
<pub-id pub-id-type="doi">10.1021/bi201862v</pub-id>
</element-citation>
</ref>
<ref id="R67">
<label>67</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krogh</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Larsson</surname>
<given-names>B</given-names>
</name>
<name>
<surname>von Heijne</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Sonnhammer</surname>
<given-names>EL</given-names>
</name>
</person-group>
<article-title>Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes</article-title>
<source>Journal of molecular biology</source>
<year>2001</year>
<volume>305</volume>
<fpage>567</fpage>
<lpage>580</lpage>
<pub-id pub-id-type="doi">10.1006/jmbi.2000.4315</pub-id>
</element-citation>
</ref>
<ref id="R68">
<label>68</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>EJ</given-names>
</name>
</person-group>
<article-title>Regulation and function of the Salmonella MgtC virulence protein</article-title>
<source>Journal of microbiology (Seoul, Korea)</source>
<year>2015</year>
<volume>53</volume>
<fpage>667</fpage>
<lpage>672</lpage>
<pub-id pub-id-type="doi">10.1007/s12275-015-5283-1</pub-id>
</element-citation>
</ref>
<ref id="R69">
<label>69</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goehring</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<article-title>Screening and large-scale expression of membrane proteins in mammalian cells for structural studies</article-title>
<source>Nat Protoc</source>
<year>2014</year>
<volume>9</volume>
<fpage>2574</fpage>
<lpage>2585</lpage>
<pub-id pub-id-type="doi">10.1038/nprot.2014.173</pub-id>
</element-citation>
</ref>
<ref id="R70">
<label>70</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zivanov</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>
<article-title>New tools for automated high-resolution cryo-EM structure determination in RELION-3</article-title>
<source>eLife</source>
<year>2018</year>
<volume>7</volume>
<pub-id pub-id-type="doi">10.7554/eLife.42166</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<title>FSEC-Nb designation and verification</title>
<p>(<bold>A</bold>) Flow chart of FSEC-Nb for membrane protein expression and purification. (<bold>B</bold>) Cartoon diagram of the FSEC system for FSEC-Nb. (<bold>C</bold>) Cartoon of a representative FSEC trace from FSEC-Nb.</p>
</caption>
<graphic xlink:href="EMS96494-f001"/>
</fig>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption>
<title>Establishing the FSEC-Nb method</title>
<p>(<bold>A</bold>) FSEC traces of unpurified ALFA peptide-tagged BbZIP with mEGFP-tagged NbALFA, as detected by mEGFP fluorescence. A close-up view of the main peak profiles for the complex of ALFA-tagged BbZIP and mEGFP-tagged NbALFA is also shown. (<bold>B</bold>) FSEC traces of unpurified BC2 peptide-tagged BbZIP with mEGFP-tagged NbBC2, as detected by mEGFP fluorescence. (<bold>C</bold>) FSEC traces of C-terminally mEGFP-tagged and muGFP-tagged BbZIP, as detected by mEGFP and muGFP fluorescence, respectively.</p>
</caption>
<graphic xlink:href="EMS96494-f002"/>
</fig>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption>
<title>Thermostability assay by FSEC-Nb</title>
<p>(<bold>A</bold>) Flow chart of the thermostability assay by FSEC-Nb. (<bold>B</bold>) Cartoon diagram of the thermostability assay by FSEC-Nb. (<bold>C</bold>) FSEC-Nb traces of unpurified ALFA-tagged hP2×3, as detected by mEGFP fluorescence. (<bold>D</bold>) FSEC-Nb traces of unpurified ALFA-tagged hP2×3 preheated at the indicated temperatures. A close-up view of the main peak profiles for the complex of the ALFA-tagged hP2×3 and mEGFP-tagged NbALFA is also shown. (<bold>E</bold>) Melting curves of hP2×3 in the presence and absence of ATP, as detected by FSEC-Nb. The fitted curves are shown as blue (apo) and green (with ATP) lines.</p>
</caption>
<graphic xlink:href="EMS96494-f003"/>
</fig>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption>
<title>Expression screening of ZAC orthologs</title>
<p>(<bold>A</bold>) FSEC-Nb traces of unpurified ALFA peptide and His8-tagged ZAC orthologs with mEGFP-tagged NbALFA, as detected by mEGFP fluorescence. A close-up view of the main peak profiles for the complex of the ALFA-tagged ZAC and mEGFP-tagged NbALFA is also shown. The expression of ZAC orthologs from <italic>Homo sapiens</italic> (GI: 206725456), <italic>Danio rerio</italic> (528523664), <italic>Oryzias latipes</italic> (765127633), and <italic>Oreochromis niloticus</italic> (542233486) was screened by FSEC-Nb. (<bold>B</bold>) FSEC traces of C-terminally muGFP-tagged OlZAC, as detected by muGFP fluorescence. (<bold>C</bold>) FSEC traces of unpurified ALTA peptide and His8-tagged ZAC orthologs with P3NTA, as detected by fluorescein fluorescence.</p>
</caption>
<graphic xlink:href="EMS96494-f004"/>
</fig>
<fig id="F5" position="float">
<label>Figure 5</label>
<caption>
<title>Expression screening of membrane proteins from SARS-CoV-2</title>
<p>FSEC-Nb traces of unpurified ALFA peptide and His8-tagged membrane proteins from SARS-CoV-2 with mEGFP-tagged NbALFA, as detected by mEGFP fluorescence. A close-up view of the main peak profiles is also shown. The expression of ORF3a (UniProt ID: P0DTC3), E (P0DTC4), M (P0DTC5), ORF7a (P0DTC7), and ORF7b (P0DTD8) was screened by FSEC-Nb.</p>
</caption>
<graphic xlink:href="EMS96494-f005"/>
</fig>
<fig id="F6" position="float">
<label>Figure 6</label>
<caption>
<title>Detergent screening for OlZAC purification</title>
<p>(<bold>A</bold>) FSEC-Nb traces of unpurified ALFA-tagged OlZAC preheated at the indicated temperatures. A close-up view of the main peak profiles is also shown. (<bold>B</bold>) Melting curves of OlZAC, as detected by FSEC-Nb. The fitted curve is shown as a black line. (<bold>C</bold>) Normalized peak heights of ALFA-tagged OlZAC preheated at 60 °C for 10 minutes solubilized with the indicated detergents. The peak heights were normalized to that from the sample solubilized with DDM at 4 °C. Error bars represent standard error of the mean (N=6).</p>
</caption>
<graphic xlink:href="EMS96494-f006"/>
</fig>
<fig id="F7" position="float">
<label>Figure 7</label>
<caption>
<title>Large-scale expression and purification of OlZAC</title>
<p>(<bold>A</bold>) FSEC profiles of OlZAC, as detected by FSEC-Nb for the optimization of cell culture conditions. (<bold>B</bold>) Time course curves of the main peak heights, as detected by FSEC-Nb. HEK293S cells were infected with P2 BacMam virus for OlZAC expression at a 1% or 2% volume. At 16 hours after virus addition, cell culture temperatures were maintained at 37 °C or shifted to 30 °C. (<bold>C</bold>) Size-exclusion chromatography of OlZAC, as detected by UV absorbance. (<bold>D</bold>) FSEC trace of purified OlZAC, as detected by Trp fluorescence. (<bold>E</bold>) SDS-PAGE of the purified OlZAC after SEC.</p>
</caption>
<graphic xlink:href="EMS96494-f007"/>
</fig>
<fig id="F8" position="float">
<label>Figure 8</label>
<caption>
<title>Negative staining EM and cryo-EM of OlZAC</title>
<p>(<bold>A, B</bold>) Negative staining EM images of OlZAC particles. (<bold>C-E</bold>) Selected 2D class averages, as calculated using RELION. (<bold>E, F</bold>) Cryo-EM image at 1.8 μm defocused with OlZAC particles.</p>
</caption>
<graphic xlink:href="EMS96494-f008"/>
</fig>
<fig id="F9" position="float">
<label>Figure 9</label>
<caption>
<title>Vector maps for FSEC-Nb</title>
<p>(<bold>A, B</bold>) Maps of the expression vectors for mEGFP-tagged (<bold>E</bold>) and mCherry-tagged (<bold>F</bold>) NbALFA. (<bold>C-F</bold>) Maps of the expression vectors for FSEC-Nb in <italic>E. coli</italic> (<bold>C, D</bold>), insect cells (<bold>E</bold>), and mammalian cells (<bold>F</bold>).</p>
</caption>
<graphic xlink:href="EMS96494-f009"/>
</fig>
</floats-group>
</article>
